Capricor Therapeutics

1 follower


Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.

Industries

Headquarters

Stage

Employees

Links

Org chart

Linda Marbán
President, CEO & Director

Linda Marbán

Collapse
Kristi A. H. Elliott
Chief Science Officer
Mark Awadalla
Vice President Clinical Research & Development Operations
Yushi Feng
VP of Regulatory Affairs
Jonathan Tayco
VP, Program Management & Business Operations
Joe Z.
Senior IP Counsel